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Summary
Within 2–3 months of in vitro culture-expansion, mesen-
chymal stromal cells (MSC) undergo replicative senes-
cence characterized by cell enlargement, loss of
differentiation potential and ultimate growth arrest. In
this study, we have analyzed DNA methylation changes
upon long-term culture of MSC by using the Human-
Methylation27 BeadChip microarray assessing 27 578
unique CpG sites. Furthermore, we have compared MSC
from young and elderly donors. Overall, methylation pat-
terns were maintained throughout both long-term cul-
ture and aging but highly signiﬁcant differences were
observed at speciﬁc CpG sites. Many of these differences
were observed in homeobox genes and genes involved
in cell differentiation. Methylation changes were veri-
ﬁed by pyrosequencing after bisulﬁte conversion and
compared to gene expression data. Notably, methylation
changes in MSC were overlapping in long-term culture
and aging in vivo. This supports the notion that replica-
tive senescence and aging represent developmental
processes that are regulated by speciﬁc epigenetic modiﬁ-
cations.
Key words: aging; DNA methylation; human mesenchy-
mal stromal cells; long-term culture; pyrosequencing;
senescence.
Introduction
Mesenchymal stromal cells (MSC) are precursors for mesoder-
mal cell lineages such as osteocytes, chondrocytes, and adipo-
cytes. They can be isolated from various tissues by plastic
adherent growth under speciﬁc culture conditions. MSC are het-
erogeneous, and reliable markers for the deﬁnition of the multi-
potent subset of ‘mesenchymal stem cells’ remain to be
elucidated (Horwitz et al., 2005; Dominici et al., 2006; Wagner
& Ho, 2007). Nevertheless, the ease of isolation and the possibil-
ity of culture expansion to very high cell numbers as well as the
absence of critical side effects of MSC in clinical trials raise hopes
for a variety of therapeutic applications (Wagner & Ho, 2007).
Mesenchymal stromal cells have a restricted lifespan in vitro
such as any other somatic cell and can therefore only be
expanded for a limited number of cell divisions before entering a
senescent state and unequivocally stopping proliferation. This is
accompanied by enlargement and morphologic changes
referred to as ‘fried egg morphology’. Furthermore, many
groups have shown that long-term culture of MSC impairs their
differentiation potential (Banﬁ et al., 2000; Baxter et al., 2004;
Bonab et al., 2006; Noer et al., 2007; Wagner et al., 2008).
Therefore, the senescent state needs to be taken into account
for quality control of MSC in cellular therapy.
The phenomenon of replicative senescence was ﬁrst described
in the 1960s by Leonard Hayﬂick (Hayﬂick, 1965) and since then
a scientiﬁc discussion is ongoing whether the so-called ‘Hayﬂick
limit’ resembles the aging process of the whole organism. We
have recently demonstrated that replicative senescence induces
reproducible gene expression changes in MSC (Wagner et al.,
2008; Schallmoser et al., 2009). Interestingly, these changes
closely resemble age-associated gene expression changes in
adult stem and progenitor cells of young vs. elderly donors
(Wagner et al., 2009). This overlap in differential gene expres-
sion indicates that long-term culture and aging might be regu-
lated by similar mechanisms.
Two different basic principles are conceivable for cellular
aging: (i) it might either be due to accumulation of damage that
leads to cellular deterioration (Kirkwood & Austad, 2000) or (ii)
it results from a cellular program that is regulated by a biological
clock (de Magalhaes & Church, 2005; Prinzinger, 2005). Various
molecular pathways have been shown to be relevant for the
process of aging and senescence such as telomere shortening,
DNA damage, accumulation of the cyclin-dependent kinase
inhibitor p16INK4a and oxidative stress (Kiyono et al., 1998;
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lO’Hare et al., 2001; Di Donna et al., 2003; Ho et al., 2005;
Janzen et al., 2006). Furthermore, it has been proposed that epi-
genetic changes such as DNA methylation play a central role in
senescence and aging (Wilson & Jones, 1983; Young & Smith,
2001; Nilsson et al., 2005; Chambers et al., 2007; Shibata et al.,
2007; Suzuki et al., 2008).
DNA methylation is the best characterized epigenetic modiﬁ-
cation. CpG dinucleotides in the mammalian genomic DNA may
be methylated at cytosine moieties. Upon replication the same
methylation pattern is established on the newly synthesized
DNA strand by DNA methyltransferase 1 (DNMT1). Thereby,
epigenetic modiﬁcations are inherited to both daughter cells
(Jaenisch & Bird, 2003). Methylation may impact gene transcrip-
tion by direct interference with transcription factors or with
methyl-CpG-binding proteins that modify histones and thereby
inactivate the respective promoter region. Other authors have
previously suggested that methylation levels gradually decrease
upon long-term culture (Wilson & Jones, 1983; Nilsson et al.,
2005). This study is based on the hypothesis that long-term
culture and aging are associated with epigenetic modiﬁcations
at speciﬁc CpG sites.
Results
Long-term culture of MSC
Mesenchymal stromal cells were isolated from bone marrow
aspirates from young donors (21–50 years) or from bone
marrow aspirates from elderly donors (53–85 years) upon hip
fracture as previously described (Wagner et al., 2009). All cell
preparations fulﬁlled the criteria of MSC such as typical growth
morphology, immunophenotype and in vitro differentiation
potential (Fig. S1) (Dominici et al., 2006; Wagner & Ho, 2007).
Within 2–3 months of long-term culture the cells underwent
replicative senescence accompanied by a decreased adipogenic
differentiation potential and an increased propensity for osteo-
genic differentiation (Wagner et al., 2008) whereas no sponta-
neous differentiation was observed under nondifferentiation
conditions even at later passages. The proliferation rate
decreased gradually until the cells ﬁnally stopped to proliferate
(Fig. S2A). These senecent passages were associated with
expression of senescence-associated beta-galactosidase
(SA-beta-gal) and increased p16 gene expression (Fig. S3).
Replicative senescence affects DNA methylation
patterns
To determine effects of long-term culture on DNA methylation
patterns we harvested MSC of early passages (2
nd passage; P2)
and late passages (P8–P15) from eight donors. Methylation
status at 27 578 CpG sites was simultaneously analyzed using
the HumanMethylation27 BeadChip microarray (Illumina).
Scatter plot analysis of methylation in early vs. late passages
revealed that DNA methylation remains overall constant upon
MSC culture expansion (Fig. 1A). However, several CpGs
showed a highly signiﬁcant degree of differential methylation
between early and late passage in all eight MSC samples. Only
differential methylation of more than 20% was considered to
be relevant and these CpGs were considered for further analysis.
Twenty-nine CpGs were hypermethylated upon long-term cul-
ture whereas 55 CpGs were hypomethylated (Fig. 1C;
Table S1). Hypermethylated CpGs were distributed in the pro-
moter regions and within 23 nonredundant and functionally
characterized genes including distal-less homeobox 5 (DLX5),
runt-related transcription factor 3 (RUNX3), and chromosome
10 open reading frame 27 (C10orf27). Hypomethylated CpGs
were localized in the promoter regions and within 43 protein-
coding genes including cycline-dependent kinase inbibitor 2B
(CDKN2B), bone morphogenic proteins 10 and 15 (BMP10⁄15),
left-right determination (LEFTY1), and distinct CpG sites within
the RUNX3 promoter. The function of all differentially methyl-
ated genes was further classiﬁed by Gene Ontology analysis.
Hypermethylated genes were signiﬁcantly over-represented in
the functional categories cell-matrix adhesion, embryonic mor-
phogenesis and development whereas hypomethylated genes
were rather associated with epidermal differentiation (Table S2).
There was only a moderate enrichment of methylation changes
in speciﬁc chromosome regions: Three of the hypermethylated
genes were located at chromosome band 10q22 (P = 0.0003)
whereas four of the hypomethylated genes were enriched at
chr21q22 (P = 0.0012). Overall, our results inevitably demon-
strate that long-term culture induces reproducible and signiﬁ-
cant methylation changes at speciﬁc CpG sites and especially
seem to affect genes involved in development.
DNA methylation changes upon aging
To further elucidate methylation changes in MSC upon aging,
we next analyzed methylation proﬁles in MSC that were taken
from the second passage of young or elderly donors, respec-
tively. Several CpG sites revealed age-associated methylation
changes (Fig. 1B). Two hundred and ninety-ﬁve CpGs were
hypermethylated, whereas 349 CpGs were hypomethylated
upon aging (Fig. 1D; Table S3). Genes associated with CpGs
that were hypermethylated upon aging included HOXA2,
HOXA5, HOXA6, HOXB2, DLX5, aristaless-like homeobox 4
(ALX4), T-box 5 isoform 2 (TBX5), RUNX2, RUNX3, O-6-meth-
ylguanin-DNA methyltransferase (MGMT) and C10orf27. Genes
associated with CpGs that were hypomethylated upon aging
included HOXB1, HOXB3, HOXB4, HOXB6, HOXD3, HOXD12,
paired-like homeodomain transcription factors PITX1 and PITX2,
sirtuin 6, BMP4, mesoderm speciﬁc transcript (MEST), paired
box genes PAX1, PAX8, PAX9, TBX1, S100A4, and also RUNX3
and ALX4. Differentially methylated genes were further classi-
ﬁed by Gene Ontology analysis. Hypermethylated genes were
signiﬁcantly over-represented in various signal transduction
pathways and limb morphogenesis. In contrast to this, hypome-
thylated genes were most signiﬁcantly over-represented in
genes involved in sequence-speciﬁc DNA binding and develop-
mental processes (Table S4). Furthermore, there was an enrich-
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55ment of hypermethylated genes at the chromosome regions
chr21q22 (9 genes; P = 0.0006), chr2p25 (5 genes;
P = 0.0011), chr6q27 (4 genes; P = 0.0013), and chr12q24 (7
genes; P = 0.0073). Hypomethylated genes upon aging were
enriched at chr20q13 (9 genes; P = 0.0032). Interestingly,
methylation changes were highly enriched in genes with simian-
virus-40-protein 1 (SP1) binding sites (hypermethylation: 15 of
258 genes, P = 7.8 · 10
)11 and hypomethylation: 31 of 273
genes, P = 6.0 · 10
)5).
Validation of differentially methylated genes by
pyrosequencing
Differential methylation of six selected CpG sites (DLX5, HOXA5,
S100A4, C10orf27, RUNX3, and CDKN2B) was validated by
pyrosequencing after bisulﬁte conversion. Candidate genes
were selected based on the correlation between gene expres-
sion and CpG island methylation as well as their attributed bio-
logical function. Methylation levels were overall slightly lower in
pyrosequencing results as compared with microarray analysis.
However, differential methylation upon long-term culture or
upon aging was very consistent between the two methods
(Fig. 2A,B). Moreover, differential methylation was also veriﬁed
in three additional independent donor samples (Fig. S4A). Com-
parative analysis of different passages revealed that methylation
changes are continuously acquired with every passage upon
long-term culture (Fig. S4B). Notably, also CpGs in close neigh-
borhood to the CpG represented on the microarray revealed
very similar methylation patterns (Fig. 2C,D; Fig. S4C,D). This
demonstrates that methylation changes are not restricted to
individual CpG sites but rather affect whole CpG islands.
Association of methylation changes in long-term
culture and aging
We have previously shown that long-term culture and aging
have similar effects on the gene expression proﬁle of MSC
(Wagner et al., 2008, 2009). Therefore, we hypothesized that
these two processes might also reveal an association in DNA
methylation changes. Only 13 CpGs were more than 20% dif-
ferentially methylated in both comparisons and therefore we
have chosen a less stringent cutoff of 15% differential methyla-
tion resulting in 80 CpGs (Fig. 3). These demonstrated a correla-
tion in long-term culture and aging (R = 0.61) and chi-square
analysis revealed a statistical signiﬁcance of 4.6 · 10
)9. Hence,
it might be speculated that senescence-associated changes are
more pronounced in samples from younger donors. Indeed, the
number of more than 20% differentially methylated CpG sites
upon long-term culture was 24% higher in younger vs. elderly
donors (248 CpG sites vs. 189 CpG sites). These data indicate
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Fig. 1 CpG methylation changes upon long-term
culture and aging. DNA methylation at 27 578
different CpG sites was analyzed using the
HumanMethylation27 BeadChip microarray.
Scatter plots represent the mean methylation levels
of mesenchymal stromal cells from early passage
vs. late passage (A) or of young vs. elderly donors
(B). Differential methylation of more than 20% was
considered to be relevant and this is demonstrated
by the dashed red lines. Heat map presentation of
differentially methylated CpGs in long-term culture
(C) and aging (D) are shown. Notably, unsupervised
hierarchical clustering of CpG sites that revealed
differential methylation in long-term culture
revealed an age-associated relationship of
methylation proﬁles.
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56that long-term culture and aging resemble two processes with
related epigenetic modiﬁcations.
Association of DNA methylation and gene
expression
DNA methylation proﬁles were integrated with gene expression
data to determine the impact of epigenetic modiﬁcations on
mRNA expression. For each CpG on the HumanMethylation27
BeadChip the corresponding gene was matched to the Affy-
metrix mRNA gene expression data by gene symbols (Wagner
et al., 2009). Signal intensity in gene expression data was used
as an indicator for gene expression levels. As expected, non-
methylated genes revealed higher gene expression levels
than methylated genes (Fig. 4A). Subsequently, we tested if
differential methylation was also reﬂected in differential gene
expression. Overall the two microarray platforms did not reveal
a clear correlation between differential CpG methylation and
differential mRNA expression in long-term culture or aging
(Fig. 4B,C). This might be due to the different sensitivity of the
two techniques: 20% differential methylation can be detected,
whereas 20% differential gene expression can not be reliably
discerned. We have selectively addressed gene expression
changes in genes that have been analyzed by pyrosequencing
and that revealed higher methylation changes. mRNA expres-
sion of these genes (DLX5, HOXA5, CDKN2B, S100A4, RUNX3,
and C10orf27) was analyzed by quantitative RT-PCR. For these
selected genes hypermethylation coincided with lower gene
expression and vice versa (Fig. 4D,E).
Discussion
Epigenetic modiﬁcations play a central role in differentiation
and development. This study indicates that modiﬁcation of DNA
methylation is also involved in replicative senescence upon long-
term culture of MSC. Furthermore, a similar pattern of differen-
tial methylation was observed between MSC from young
and elderly donors. These results support the perception that
replicative senescence and aging are not only due to stochastic
accumulation of cellular defects but rather represent a develop-
mental program. On the other hand, the process is overlaid by
stress-induced senescence changes e.g. due to high oxygen
content or the artiﬁcial environment. Furthermore, the cellular
aging of MSC might be accompanied by a different composition
of heterogeneous subpopulations and loss of self-renewal
potential under in vitro conditions. Hence, senescence of MSC
has many facets that need to be further elucidated (Wagner
et al., review submitted).
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Fig. 2 Pyrosequencing of differentially
methylated CpGs. For six CpG sites differential
methylation of the HumanMethylation27
BeadChip (open circles) was validated by
pyrosequencing (ﬁlled circles) (all 16 samples,
± SEM). Overall, methylation levels were lower in
pyrosequencing but there was a striking correlation
in differential methylation between the two
methods for long-term culture (A) and aging (B).
This differential methylation was also observed in
CpGs in close vicinity to the analyzed CpG site
represented on the microarray (blue box; C, D). The
percentage of methylation at each CpG site is
indicated in black.
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57Methylation was analyzed by using the novel HumanMethyla-
tion27 BeadChip representing 27 578 CpGs that are associated
with promoter regions of more than 13 500 annotated genes.
This array was designed to cover CpG dinucleotides in the
promoter region of genes and therefore is clearly biased toward
the assessment of gene-speciﬁc methylation. Differential CpG
methylation was highly reproducible in different donor samples
and was veriﬁed by pyrosequencing for all sequences tested.
Thus, this technique facilitates reliable proﬁling of global methyl-
ation patterns.
Other authors have reported that global DNA methylation
levels decrease upon long-term culture (Wilson & Jones, 1983;
Young & Smith, 2001). Therefore, it has been speculated that
maintenance of DNA methylation by DNA methyltransferase 1
(DNMT1) is incomplete resulting in a gradual decrease of DNA
methylation with repeated cell cycles (Nilsson et al., 2005).
However, our results did not reveal an overall decrease in DNA
methylation levels. In fact, methylation remained constant over
the whole culture period at most CpG sites represented on the
BeadChip. To our knowledge this study demonstrates for the
ﬁrst time that only speciﬁc CpG islands become differentially
methylated upon long-term culture. DNA methylation changes
upon aging may also depend on individual differences although
differential methylation was veriﬁed by pyrosequencing in inde-
pendent donor samples. It is also likely, that age-related changes
are inﬂuenced by the different cellular composition upon aging
as well as by the different tissue and isolation technique.
Methylation changes in our study were often associated with
homeobox genes. Expression of these genes is tightly regulated
under temporal control during vertebrate development. It has
been shown that chromatin modiﬁcations play an important
role for regulation of the ‘Hox clock’ that coordinates body pat-
terning (Illingworth et al., 2008; Soshnikova & Duboule, 2009).
Furthermore, age-associated gene expression changes have
been described in homeobox genes (Stelnicki et al., 1998;
Wagner et al., 2009) and it is conceivable that they are involved
in the timing of aging. Exemplarily, we have veriﬁed differential
methylation for HOXA5 and DLX5 upon long-term culture and
aging by pyrosequencing. The homeobox gene DLX5 is also
involved in differentiation toward the osteoblastic lineage (Lee
et al., 2005). Therefore, hypermethylation and decreased gene
expression of DLX5 might be relevant for the impaired differenti-
ation capacity of MSC upon long-term culture. It has been
shown that methylation changes at speciﬁc CpG sites can affect
differentiation of MSC (Noer et al., 2007; Zimmermann et al.,
2008). In addition, age-related methylation changes have been
described. Several tumor suppressor genes are hypermethylated
upon aging with potential implications for cancer susceptibility
in the elderly (So et al., 2006). Among these was RUNX3
that revealed age-associated changes in our analysis. Another
differentially methylated gene was the cycline-dependent kinase
inbibitor 2B (CDKN2B) that has been implicated in senescence in
our previous work (Schallmoser et al., 2009).
Several genes such as RUNX3 and ALX4 were more than 20%
hypermethylated at speciﬁc CpG sites and more than 20%
hypomethylated in others. These antagonistic modiﬁcations
within the same promoter region indicate that DNA modiﬁca-
tions are restricted to relatively short and speciﬁc sequences. On
the other hand, pyrosequencing revealed that methylation
changes are not restricted to unique CpG sites but also include
neighboring cytidines of the same CpG island. It has been
suggested that senescence can also be induced in immortal cells
by treatment with 5aza-2deoxycytidine (5AZA) (Vogt et al.,
1998). However, it is difﬁcult to discern toxic effects of 5AZA.
The complex pattern of hypermethylation and hypomethylation
observed in this study might explain why replicative senescence
cannot be controlled by demethylating agents.
De novo methylation is facilitated by DNA methyltransferases
DNMT3A and DNMT3B but it is mostly unknown how the extent
of de novo methylation is regulated and where it takes place.
Active DNA hypomethylation is also considered to occur but a
speciﬁc enzyme that removes the methyl group from 5-methyl-
cytosine has not yet been described. It has been suggested
that DNA methyltransferases exhibit dual actions in CpG methyl-
ation and demethylation of 5mCpGs through deamination
(Kangaspeska et al., 2008; Metivier et al., 2008). DNA methyla-
tion patterns may vary drastically within CpG islands and only
methylation of a deﬁned core-region silences gene expression
(Gonzalgo et al., 1998; Deng et al., 1999; Ushijima & Okochi-
Takada, 2005). We have shown that age-associated hyper-
methylated and hypomethylated genes are enriched in SP1 tran-
scription factor binding sites and it has been proposed that
binding of the SP1 transcription factor protects CpG islands
from methylation (Brandeis et al., 1994; Macleod et al., 1994).
‘Seeds of methylation’ is another interesting mechanism that
Fig. 3 Comparison of differential methylation upon long-term culture and
aging. Methylation changes upon long-term culture were plotted against
methylation changes upon aging. CpGs with a more than 15% differential
methylation in both comparisons are depicted (red spots). These differentially
methylated CpGs revealed that DNA methylation changes upon long-term
culture and aging are overlapping (correlation coefﬁcient R = 0.61;
P = 4.6 · 10
9).
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58leads to increasing methylation of CpG islands. This hypothesis
is based on the observation that little methylation is induced in
an initially nonmethylated region whereas a high degree of
methylation is induced in a sparsely methylated region (Song
et al., 2002; Stirzaker et al., 2004). This mechanism might serve
as a cell-cycle counter.
It is commonly accepted that DNA methylation silences gene
expression. This is also reﬂected by the correlation of the two dif-
ferent levels investigated in our study: nonmethylated genes
revealed higher signal intensity in mRNA expression proﬁling.
However,differentialDNAmethylationatspeciﬁcCpGsites does
notnecessarilycorrelatewithobservedgeneexpressionchanges.
Relevant fold-changes in gene expression can only be expected if
theCpGsitesarepredominantlymethylated.Itisalsoconceivable
that selective modiﬁcation of speciﬁc promoter regions either
activatesorinactivatesbindingoftranscriptionregulators.
We have previously described age-related gene expression
changes in human stem and progenitor cells and observed a
moderate but signiﬁcant concordance in the expression proﬁles
upon aging in vivo and replicative senescence in vitro (Wagner
et al., 2009). However, the proliferation rate was not higher
in MSC from younger donors and they did not reach a higher
number of cumulative population doublings. This might be
attributed to the relatively low number of samples per group as
other authors reported an inverse relationship between donor
age and the replicative life span in vitro for ﬁbroblasts or MSC
(Schneider & Mitsui, 1976; Stenderup et al., 2003; Mareschi
et al., 2006; Shibata et al., 2007). Also the doubling time of
either freshly isolated marrow cells or MSC of early passage has
been described to be signiﬁcantly lower in samples from elderly
people (Zhou et al., 2008) whereas this was not observed in our
study. Analysis of age-speciﬁc changes might be affected by the
different sources for MSC that were available for the two age
groups. MSC were either isolated from human bone marrow
from the iliac crest or from the femoral head. There were no
differences in growth, cell morphology, immunophenotype or
differentiation potential (Wagner et al., 2009). Thus, MSC from
BM and HIP fulﬁlled the criteria that are commonly used for
deﬁnition of MSC although these cell preparations are hetero-
geneous and may comprise different subpopulations (Dominici
et al., 2006; Wagner & Ho, 2007). However, we can not exclude
that some of the methylation changes are due to the different
bone marrow regions. Notably, however, there was a relevant
overlap of methylation changes upon long-term culture and
aging of MSC. Furthermore, there is a signiﬁcant concordance
of our age-related changes in MSC and age-associated methyla-
tion changes in ovarian cancer samples (Teschendorff et al.,
manuscript in preparation). Further integrative analysis of
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Fig. 4 Correlation of DNA methylation and gene expression. DNA methylation data of the HumanMethylation27 BeadChip was matched with Affymetrix
mRNA expression proﬁles. As expected, signal intensity in gene expression data revealed higher expression of nonmethylated genes (A). However, differential
methylation upon long-term culture (B) or aging (C) was not necessarily reﬂected in differential gene expression. Six differentially methylated genes that have
been analyzed by pyrosequencing were further analysed by quantitative RT-PCR and in this subset hypermethylation coincides with lower gene expression and
vice versa (D, E) (all 16 samples, ± SEM).
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59methylation proﬁles of different cell types and tissues will help
to discern the existence of a distinct methylation signature for
aging.
Bone marrow is a complex tissue with various different cell
types. Hence, it is apparent that aging and replicative senes-
cence are not identical despite molecular similarities of the two
processes. Long-term culture has been shown to impair differen-
tiation potential of MSC, especially of adipogenic differentiation
(Baxter et al., 2004; Bonab et al., 2006; Wagner et al., 2008).
By contrast, other authors demonstrated that aging activates
adipogenic differentiation and suppresses osteogenic differenti-
ation (Moerman et al., 2004; Zhou et al., 2008). These authors
also demonstrated that expression of the master transcription
factor for osteoblast differentiation RUNX2 and DLX5 decreased
upon aging and this is in line with higher methylation as
observed in our data. It is conceivable, that the higher propensity
for adipogenesis in BM of elderly people results in a lower
number of osteogenic progenitor cells.
Aging is not an inevitable fate of all cells. Our germ line cells
and their progeny are sustained through the generations and
embryonic stem cells as well as induced pluripotent stem cells
do not show signs of replicative senescence upon long-term cul-
ture (Zeng, 2007). It is therefore conceivable, that the loss of
pluripotency is directly accompanied with limitation of the repli-
cative live span (Marciniak-Czochra et al., 2009). Both mecha-
nisms might be regulated by similar epigenetic modiﬁcations
that govern differentiation and development. Our results dem-
onstrate that speciﬁc CpG sites become either methylated or
demethylated upon long-term culture. Analysis of these speciﬁc
CpG sites might facilitate monitoring of the replicative lifespan
of cells. It will be of central interest to further increase our
understanding of the mechanisms regulating senescence-associ-
ated and age-associated epigenetic modiﬁcations.
Experimental procedures
Isolation of MSC from human bone marrow
Mesenchymal stromal cells were isolated from human bone
marrow that was either taken from aspirates from healthy
donors for allogeneic transplantation (BM) or from the caput
femoris from elderly patients undergoing femoral head prosthe-
sis (HIP) as described in our previous work (Wagner et al., 2009).
All samples were taken after written consent using guidelines
approved by the Ethic Committee on the Use of Human Subjects
at the University of Heidelberg. The standardized culture condi-
tions have been described in detail before (Reyes et al., 2001;
Wagner et al., 2005).
Expansion and sampling of MSC
Mesenchymal stromal cells were cultured for 2–3 month by
serial passaging until the cells reached a senescent state and
stopped proliferation. Culture conditions and sampling have
been described in our previous work (Wagner et al., 2008,
2009). In brief, 7–10 days after the initial seeding of MNC the
colonies were trypsinized and re-plated in a new culture ﬂask
(passage 1, P1). Upon sub-conﬂuent growth (70%), cells were
re-plated at a density of 10
4 cells cm
)2. Cells were counted
at every passage by a Neubauer counting chamber and the
cumulative population doublings were calculated (Cristofalo
et al., 1998). As cell numbers were ﬁrst determined at P1, the
cumulative doubling number was ﬁrst calculated for P2. From P2
onward, there were enough cells for simultaneous expansion of
one fraction and harvesting another fraction for subsequent
analyses: 10
6 cells were lysed in TRIzol for RNAisolation, 10
6cells
were cryopreserved for immunophenotyping and in vitro differ-
entiation assays (Wagner et al., 2008, 2009) and 10
6 cells were
pelleted and storedby )80  C for subsequentDNA isolation.
Immunophenotypic analysis of MSC and in vitro
differentiation of MSC
Immunophenotypic characterization of MSC preparations was
performed on a three-color FACScan (Becton Dickinson [BD],
San Jose, CA, USA) with a ﬁve-color upgrade (Cytek Dev. Inc.,
Fremont, CA, USA) using the commonly used panel of anti-
bodies as described before (Wagner et al., 2009): CD13-allo-
phycocyanin (APC, clone WM15, BD), CD29-ﬂuorescein
isothiocyanate (FITC, MEM-101a, abcam, Cambridge, UK),
CD31-FITC (BD), CD34-phycoerythrin (PE, 8G12, BD), CD44-PE
(g44-26, BD), CD45-FITC (2D1, BD), CD73-PE (AD2, BD), CD90-
PE (G7, BD), CD105-PE (MHCD10504, BD), CD146-PE (P1H12,
BD), CD166-PE (3A6, BD), CD184-PE (12G5, BD). Osteogenic
and adipogenic differentiation of MSC was induced as previ-
ously described (Wagner et al., 2009). After 21 days osteogenic
differentiation was analyzed by Alizarin red staining and
adipogenic differentiation by Oil Red-O staining.
Senescence-associated beta-galactosidase staining
Expression of pH-dependent senescence-associated beta-
galactosidase (SA-beta-gal) activity was analyzed simultaneously
in different passages of MSC of young and elderly donors using
the SA-beta-gal staining kit (Cell Signaling Technology, Boston,
MA, USA).
DNA isolation and bisulﬁte conversion
Genomic DNA of 10
6 MSC was isolated using the QIAGEN DNA
Blood Midi-Kit. DNA quality was assessed with a NanoDrop
ND-1000 spectrometer (NanoDrop Technologies, Wilmigton,
DE, USA) and average fragment length was assessed by gel
electrophoresis. Genomic DNA (500 ng) from each sample was
bisulﬁte converted using the EZ-96 DNA Methylation Kit (Zymo
research Corporation, Orange, CA, USA). This step leads to the
deamination of nonmethylated cytosines to uracils, while
methylated cytosines are refractory to the effects of bisulﬁte and
remain cytosine. After bisulfate conversion each sample was
whole genome ampliﬁed and enzymatically fragmented.
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The HumanMethylation27 BeadChip (Illumina, San Diego, CA,
USA) uses Inﬁnium technology, previously described for SNP
genotyping (Steemers et al., 2006), to perform genome-wide
screening of DNA methylation patterns. In detail, the Human-
Methylation27 panel targets 27 578 unique CpG sites located
within the proximal promoter regions of transcription start sites
of 14 475 consensus coding sequencing (CCDS) in the NCBI
Database (Genome Build 36). In addition, 254 assays cover
110 miRNA promoters. On average, two assays were selected
per CCDS gene and from 3 to 20 CpG sites for >200 cancer-
related and imprinted genes. Further speciﬁcations of the
platform can be found at http://www.illumina.com/products/
inﬁnium_humanmethylation27_beadchip_kits.ilmn. About 200
ng DNA was applied per BeadChip according to the
manufacturer’s instructions. During hybridization, the DNA
molecules anneal to two different bead types with locus-
speciﬁc DNA oligomers – one corresponds to the methylated
(C) and the other to the unmethylated (T) state. Allele-speciﬁc
primer annealing is followed by single-base extension using
DNP- and Biotin-labeled ddNTPs. After extension, the array
is ﬂuorescently stained, scanned, and the intensities of the
unmethylated and methylated bead types measured. Initial
data analysis was performed with the BeadStudio Methylation
Module. DNA methylation values, described as beta values, are
recorded for each locus in each sample. Only few CpG sites did
not reveal reliable signals, as determined by their detection
P-value, and were therefore excluded from further analysis.
Raw data were quantile normalized. Statistical analysis and
clustering by Euclidian distance was performed using the
MultiExperiment Viewer (MeV, TM4) (Saeed et al., 2003). For
further analysis we have selected CpG sites with more than
20% differential methylation. These were further analyzed to
calculate mean methylation, differential methylation and stu-
dent’s t-test. Furthermore, genes associated to the differentially
methylated CpG sites were categorized by Gene Ontology
analysis using GoMiner software (http://discover.nci.nih.gov/
gominer/). Chromosomal distribution and transcription factor
binding was assessed by Gene Set Enrichment Analysis (Subra-
manian et al., 2005). The complete CpG methylation values
have been deposited in NCBIs Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo/) and are accessible through
GEO Series accession number GSE17448.
Pyrosequencing
Methylation changes of six selected CpG sites were validated
by pyrosequencing. Independent bisulﬁte treatment and
pyrosequencing assays were performed by Varionostic GmbH
(Ulm, Germany). In brief, bisulﬁte converted DNA was subjected
to PCR ampliﬁcation. Primers are provided in Table S5.
40–45 lL of PCR product was immobilized to 3 lL Streptavidin
SepharoseTM HP beads (GE Healthcare, Piscataway, NJ, USA)
followed by annealing to 2 lL sequencing primer (5 lM) for 2¢
at 80  C. CpG analysis was done with Pyro Q-CpG software,
and differential methylation was calculated as described above.
Gene expression proﬁling
In this study we have combined DNA methylation data with
gene expression proﬁles of our previous work (Wagner et al.,
2008, 2009). Gene expression proﬁles have been analyzed by
the U133_Plus_2.0 Affymetrix chip and two different data sets
were used for this comparison.
1 MSC-replicative senescence (Wagner et al., 2008): MSC of
three different donors were analyzed at passage 2 (P2) and at
the senescent passage (Px). This resulted in a set of six hybridiz-
ations. Raw data were quantile normalized and log2 ratios were
calculated vs. P2 of the corresponding donor sample. The
complete microarray data are accessible through GEO Series
accession number GSE9593.
2 MSC-donor age (Wagner et al., 2009): MSC of four
younger donors (21–50 years) and four elderly donors
(53-85 years) were harvested at the second passage. These are
the same donor samples that have also been used for methyl-
ation proﬁling. Raw data were quantile normalized and log2
ratios were calculated between the different age groups. The
complete microarray data are accessible through GEO Series
accession number GSE12274.
Gene expression data was matched to HumanMethylation27
BeadChip by gene symbols (HUGO names). For comparative
analysis we have only considered probe sets that were detected
as present in more than 50% of the hybridizations in gene
expression analysis.
Quantitative real-time PCR analysis
Quantiﬁcation of mRNA expression for candidate genes was
performed by real-time quantitative PCR (QRT-PCR) using the
ABI PRISM
  7700HT Sequence Detection System Instrument
(Applied Biosystems, Applera Deutschland GmbH, Darmstadt,
Germany). Total RNA was isolated and reverse transcribed as
described in our previous work (Wagner et al., 2009). Primers
were obtained from Biospring (Frankfurt, Germany) (Table S5).
QRT-PCR reactions were performed with the power SYBR
 
green PCR master mix in a MicroAmp optical 96-well reaction
plate with a ABI PRISM
  7700HT sequence detector (Applied
Biosystems) according to the manufacturer’s instructions. Gene
expression levels were normalized to GAPDH expression, which
was used as a housekeeping gene.
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